Form 4 for GILD Gilead Sciences
Accepted 2023-05-04 00:00:00 ET · period of report 2023-05-03 · accession 0001127602-23-014544 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-05-04 | 2023-05-03 | GILD | WELTERS ANTHONY | Dir | A - Grant | $0.00 | +1,887 | 7,922 | +31% | $0 |
| D | 2023-05-04 | 2023-05-03 | GILD | WELTERS ANTHONY | Dir | A - Grant | $79.45 | +10.2K | 10.2K | New | +$808.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-05-03 | A | A | 1,887 | $0.00 | 7,922 | D | — | — | (F1) Represents 1,887 restricted stock units ("RSUs") granted under the Gilead Sciences, Inc. 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. The RSUs vested immediately upon the grant date of May 3, 2023. |
| 2 | Derivative | Non-qualified Stock Option (Right to Buy) | 2023-05-03 | A | A | 10,173 | $79.45 | 10,173 | D | $79.45 · — to 2033-05-03 | 10,173 Common Stock | (F2) 100% of the shares subject to the stock option vested immediately upon the grant date of May 3, 2023. |